Live feed
Filing
SC 13D/A
SC 13D/A0001193125-21-231559·Inozyme Pharma, Inc.
Schedule 13D ownership disclosure
INOZYME PHARMA INC
Security class unavailable · CUSIP: 45790W108
Event date: 2021-07-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-21-231559
- Form type
- SC 13D/A
- Filer
- Inozyme Pharma, Inc.
- CIK
- CIK 1693011
- Filed
- Jul 30, 2021
- Reporting period
- Jul 26, 2021
- Description
- Schedule 13D beneficial ownership